PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11967252-3	2002	The objective of this study was to determine the effects of celecoxib compared with placebo on 24-hour BP levels in ACE inhibitor-treated patients with hypertension.	Celecoxib	60-69	angiotensin I converting enzyme	Homo sapiens	116-119	
35105633-6	2022	METHODS: The Adjunctive CElecoxib in childhood-onset OCD (ACE-OCD) study is a single-centre randomised, quadruple-blind, placebo-controlled superiority trial with two parallel groups: celecoxib 100 mg twice daily and placebo.	Celecoxib	24-33	angiotensin I converting enzyme	Homo sapiens	58-61	
35105633-6	2022	METHODS: The Adjunctive CElecoxib in childhood-onset OCD (ACE-OCD) study is a single-centre randomised, quadruple-blind, placebo-controlled superiority trial with two parallel groups: celecoxib 100 mg twice daily and placebo.	Celecoxib	184-193	angiotensin I converting enzyme	Homo sapiens	58-61